SEBELA PHARMACEUTICALS INC. RXDIRECT

Serial Number 87751799
Registration 5734869
710

Registration Progress

Application Filed
Jan 11, 2018
Under Examination
Oct 23, 2018
Approved for Publication
Aug 28, 2018
Published for Opposition
Aug 28, 2018
Registered
Apr 23, 2019

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SEBELA PHARMACEUTICALS INC. RXDIRECT
Previous Owner: SEBELA IRELAND LIMITED

Trademark Image

SEBELA PHARMACEUTICALS INC. RXDIRECT

Basic Information

Serial Number
87751799
Registration Number
5734869
Filing Date
January 11, 2018
Registration Date
April 23, 2019
Published for Opposition
August 28, 2018
Cancellation Date
November 7, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Nov 7, 2025

Rights Holder

SEBELA IRELAND LIMITED

11
Address
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS,
PETER STREET
DUBLIN 8
IE

Ownership History

Sebela International Limited

Original Applicant
99
Hamilton BM

SEBELA INTERNATIONAL BERMUDA LIMITED

New Owner Before Publication #1
11
HAMILTON BM

SEBELA INTERNATIONAL BERMUDA LIMITED

Owner at Publication
11
HAMILTON BM

SEBELA INTERNATIONAL BERMUDA LIMITED

Original Registrant
11
HAMILTON BM

SEBELA IRELAND LIMITED

New Owner After Registration #1
11
DUBLIN IE

Legal Representation

Attorney
Jeffrey H. Handelsman

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Nov 7, 2025 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Apr 23, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 24, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 23, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 20, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 19, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 19, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 27, 2019 IUAF S USE AMENDMENT FILED Loading...
Mar 19, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 27, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 23, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 28, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 28, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 8, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 4, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 28, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 27, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 27, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 2, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 2, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 2, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 23, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 26, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 25, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 15, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the stylized wording "SEBELA" above the stylized wording "PHARMACEUTICALS INC." which is above the stylized wording "RxDIRECT" appearing within a box and arrow design, all to the right of a curved design with a horizontal line and three dots.
Color Claim
Color is not claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS INC." AND "RXDIRECT"